Physician

Michael John Allingham, M.D., PH.D.

According to 2025 Medicare claims, Michael Allingham, M.D., PH.D. (NPI: 1285878124) practices ophthalmology in the Raleigh-Cary, NC market, with the plurality of this provider's patient population coming from Wake, NC. This provider's primary affiliated billing organization is DUKE HEALTH INTEGRATED PRACTICE, INC. (NPI: 1205553369; TIN: 862109896) and primary practice location at 27518-8506. Allingham is affiliated with the Duke Connected Care, LLC (ACO ID: A2419), participating under the MSSP model.

Allingham's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 634 traditional Medicare patients, billed 22,686 HCPCS/CPT codes, and received $1,968,615 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 343 prescription claims across 79 beneficiaries totaling $38,926 in drug costs, led by Restasis (Cyclosporine). Open Payments data shows 7 records totaling $29,050. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $285,732 to $1,968,615. Similarly, Part D prescription costs have moved sharply higher in recent years, from $4,003 to $38,926. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	160	1,315	$285,732
2016	358	3,920	$945,209
2017	340	4,773	$1,213,412
2018	354	5,294	$1,324,940
2019	326	5,241	$1,333,305
2020	357	5,001	$1,163,215
2021	503	6,448	$1,557,755
2022	573	7,847	$1,695,526
2023	561	13,036	$1,694,096
2024	634	22,686	$1,968,615

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	18	46	$4,003
2016	38	123	$9,952
2017	52	194	$17,204
2018	64	185	$21,638
2019	67	255	$27,930
2020	66	220	$22,885
2021	69	195	$23,157
2022	75	267	$38,407
2023	81	288	$36,181
2024	79	343	$38,926

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
67028	Injection of drug into eye	217	1,103	$86
92014	Established patient complete exam of visual system	541	901	$83
92134	Imaging of retina	447	1,417	$27
92250	Photography of the retina	243	325	$23
92202	Extended exam of the back part of the eye with optic nerve drawing	362	507	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Restasis	Cyclosporine	15	540	$11,497
Bromfenac Sodium	Bromfenac Sodium	18	868	$5,276
Prednisolone Acetate	Prednisolone Acetate	48	1,873	$2,188
Latanoprost	Latanoprost	76	4,230	$825
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	39	2,671	$732

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	7	$29,050	Astellas Pharma Global Development
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Michael John Allingham, M.D., PH.D.?

Tedicare shows public-source Medicare data for Michael John Allingham, M.D., PH.D. (NPI 1285878124), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael John Allingham, M.D., PH.D. have ACO affiliation data?

Michael John Allingham, M.D., PH.D. is shown with ACO affiliation data for Duke Connected Care, LLC (MSSP, ACO ID A2419).

What billing organization is linked to Michael John Allingham, M.D., PH.D.?

Michael John Allingham, M.D., PH.D. is linked to DUKE HEALTH INTEGRATED PRACTICE, INC. (billing NPI 1205553369) in the available physician profile data.

Does Michael John Allingham, M.D., PH.D. have Open Payments data?

Michael John Allingham, M.D., PH.D. has 7 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.